Literature DB >> 22330778

Determination of plasma fibrinogen concentrations in beagle dogs, cynomolgus monkeys, New Zealand white rabbits, and Sprague-Dawley rats by using Clauss and prothrombin-time-derived assays.

Mehrdad Ameri1, Henry A Schnaars, John R Sibley, David J Honor.   

Abstract

The most widely used technique for determination of fibrinogen concentration is the Clauss fibrinogen (FIB(Clauss)) assay, which measures the clotting time of plasma after addition of excess thrombin. More recently, the PT-derived fibrinogen (FIB(PT)) assay has been developed, based on the relationship between fibrinogen concentration and the kinetics of clot formation during the prothrombin time. The objective of this study was to compare the fibrinogen concentration determined by the FIB(Clauss) and FIB(PT) assays in citrated plasma samples from healthy dogs (n = 40), monkeys (n = 40), rabbits (n = 26), and rats (n = 58) by using an automated coagulation analyzer. Results of a t test analysis indicated that the mean plasma fibrinogen concentrations measured by the 2 assays for all 4 species were significantly different. According to Pearson correlation coefficients, the FIB(PT) assay displayed a high correlation (0.93 to 0.98) with the FIB(Clauss) assay for all species. When the FIB(PT) and FIB(Clauss) assays were compared by using Deming regression, positive or negative constant and proportional biases emerged for all species. Intra- and interassay coefficients of variation for the FIB(PT) and FI(BClauss) assays were 0.8% to 2.3% and 1.8% to 7.4%, respectively. In conclusion, the FIB(PT) assay is a rapid and economical method for estimating fibrinogen concentration in plasma samples from dogs, monkeys, rabbits, and rats. However, it should not be used without restriction. Further studies are required to investigate the performance of this assay in animals with various pathologic states, including coagulopathy, dysfibrinogenemia, and hypo- or hyperfibrinogenemia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22330778      PMCID: PMC3228922     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  17 in total

1.  A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen.

Authors:  J Mackie; A S Lawrie; S Kitchen; P J Gaffney; D Howarth; G D O Lowe; J Martin; G Purdy; P Rigsby; A Rumley
Journal:  Thromb Haemost       Date:  2002-06       Impact factor: 5.249

2.  Measurement of plasma fibrinogen concentration by the prothrombin-time-derived method: applicability and limitations.

Authors:  R De Cristofaro; R Landolfi
Journal:  Blood Coagul Fibrinolysis       Date:  1998-04       Impact factor: 1.276

3.  Degree of agreement in plasma fibrinogen among two functional and one immunonephelometric assays.

Authors:  B Magnani; T Fenton; C Lapp; C Brugnara
Journal:  Am J Clin Pathol       Date:  1997-05       Impact factor: 2.493

Review 4.  Specific assays of hemostasis proteins: fibrinogen.

Authors:  G Palareti; M Maccaferri
Journal:  Ric Clin Lab       Date:  1990 Apr-Jun

5.  Discrepancy between fibrinogen concentrations determined by clotting rate and clottability assays during the acute-phase reaction.

Authors:  T Jensen; S Halvorsen; H C Godal; P M Sandset; O H Skjøonsberg
Journal:  Thromb Res       Date:  2000-12-01       Impact factor: 3.944

6.  Human plasma fibrinogen measurement derived from activated partial thromboplastin time clot formation.

Authors:  F Sobas; M Hanss; P Ffrench; M C Trzeciak; M Dechavanne; C Négrier
Journal:  Blood Coagul Fibrinolysis       Date:  2002-01       Impact factor: 1.276

Review 7.  Plasma fibrinogen.

Authors:  Gordon D O Lowe; Ann Rumley; Ian J Mackie
Journal:  Ann Clin Biochem       Date:  2004-11       Impact factor: 2.057

Review 8.  Fibrinogen and fibrin structure and functions.

Authors:  M W Mosesson
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

Review 9.  Laboratory testing for fibrinogen abnormalities.

Authors:  Madeleine Verhovsek; Karen A Moffat; Catherine P M Hayward
Journal:  Am J Hematol       Date:  2008-12       Impact factor: 10.047

10.  Prothrombin time derived fibrinogen determination on Sysmex CA-6000.

Authors:  A S Lawrie; S J McDonald; G Purdy; I J Mackie; S J Machin
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

View more
  3 in total

1.  Melaleuca alternifolia formulations in the treatment of experimental pythiosis.

Authors:  Júlia de Souza Silveira; Carolina Litchina Brasil; Caroline Quintana Braga; Ândrios da Silva Moreira; Helen Cabaldi Franz; Rosimeri Zamboni; Eliza Simone Sallis; Ana Paula Albano; Cristina Gomes Zambrano; Lara Colles Araujo; Cristiane de Bona da Silva; Luciana Pötter; Sônia de Avila Botton; Daniela Isabel Brayer Pereira
Journal:  Braz J Microbiol       Date:  2022-03-03       Impact factor: 2.214

2.  Prothrombin Time, Activated Partial Thromboplastin Time, and Fibrinogen Reference Intervals for Inbred Strain 13/N Guinea Pigs (Cavia porcellus) and Validation of Low Volume Sample Analysis.

Authors:  Jillian A Condrey; Timothy Flietstra; Kaitlyn M Nestor; Elizabeth L Schlosser; JoAnn D Coleman-McCray; Sarah C Genzer; Stephen R Welch; Jessica R Spengler
Journal:  Microorganisms       Date:  2020-07-27

3.  Correlation of plasma coagulation tests and fibrinogenClauss with rotational thromboelastometry parameters and prediction of bleeding in dogs.

Authors:  Nathalie M Enk; Annette P N Kutter; Claudia Kuemmerle-Fraune; Nadja E Sigrist
Journal:  J Vet Intern Med       Date:  2018-12-11       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.